Related News
Merck to build Jiangsu pharmaceutical plant to manufacture 3 drugs
Online Edition
GERMANY-BASED Merck, a leading company in the pharmaceutical and chemical sectors, will spend 650 million yuan (US$104.84 million) in Nantong, Jiangsu Province, to build a new pharmaceutical plant next month, Merck officials said in Shanghai today.
The plant will start operating in 2017 and produce only three medicines - all of them included on the basic medicine list covered by China's medical insurance. The three medicines treat hypertension, diabetes and thyroid disorder.
Merck is the first multinational company to invest heavily in a new plant specifically to produce medicines covered by China's medical insurance.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
